These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo. Truitt RL, Shih CY, Lefever AV, Tempelis LD, Andreani M, Bortin MM. J Immunol; 1983 Oct 01; 131(4):2050-8. PubMed ID: 6194224 [Abstract] [Full Text] [Related]
25. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems. Azuma H, Phillips JD, Green WR. J Immunol; 1987 Oct 01; 139(7):2464-73. PubMed ID: 2821116 [Abstract] [Full Text] [Related]
26. [Model of viral leukemogenesis in mice (II)]. Rupniewska ZM. Acta Haematol Pol; 1983 Oct 01; 14(3-4):229-40. PubMed ID: 6087593 [No Abstract] [Full Text] [Related]
27. AKR mouse leukemic cells in tissue culture. II. Immunologic studies on the AKR 87 cell line. Duś D, Harlozińska A, Skriabin A, Richter R. Arch Immunol Ther Exp (Warsz); 1976 Oct 01; 24(5):727-40. PubMed ID: 187141 [Abstract] [Full Text] [Related]
29. H-2-restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous leukemia virus-induced tumors: correlation of tumor cell susceptibility with expression of the gross cell surface antigen. Green WR. J Immunol; 1980 Dec 01; 125(6):2584-90. PubMed ID: 6159413 [No Abstract] [Full Text] [Related]
30. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease. Johnson BD, Drobyski WR, Truitt RL. Bone Marrow Transplant; 1993 Apr 01; 11(4):329-36. PubMed ID: 8485480 [Abstract] [Full Text] [Related]
31. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype. Green WR. J Immunol; 1984 May 01; 132(5):2665-71. PubMed ID: 6425410 [Abstract] [Full Text] [Related]
32. Murine leukemia virus env-gene expression in preleukemic thymocytes and leukemia cells of AKR strain mice. Famulari NG, Tung JS, O'Donnell PV, Fleissner E. Cold Spring Harb Symp Quant Biol; 1980 May 01; 44 Pt 2,():1281-7. PubMed ID: 6253202 [No Abstract] [Full Text] [Related]
33. Erythroid leukemia induced by Friend lymphatic leukemia virus in T-cell-depleted mice. Dawson PJ, Dresler SL, Fieldsteel AH. Cancer Res; 1979 May 01; 39(5):1611-5. PubMed ID: 311686 [Abstract] [Full Text] [Related]
34. Triggering of leukemia in thymectomized AKR mice by a membrane fraction of thymic stroma. Fournier M, Potworowski EF. Thymus; 1983 Mar 01; 5(2):89-94. PubMed ID: 6602405 [Abstract] [Full Text] [Related]
35. [Relations between the capacity of thymic repeopling and the formation of lymphoma obtained by radiation-induced preleukemic cells in C57BL/Ka mice]. Rongy AM, Defresne MP, Greimers R, Humblet C, Boniver J. C R Seances Soc Biol Fil; 1987 Mar 01; 181(1):88-93. PubMed ID: 2954627 [Abstract] [Full Text] [Related]
36. AKR murine leukemia viruses and long-term bone marrow cultures from AKR and SJL mice. Hays EF, Warren J, Hale L, Rodensky D. Exp Hematol; 1980 Jan 01; 8(1):134-46. PubMed ID: 6250871 [Abstract] [Full Text] [Related]
37. Cellular changes in the thymuses of preleukemic AKR mice: correlation with changes in the expression of murine leukemia viruses. Nowinski RC, Doyle T. Cell; 1977 Oct 01; 12(2):341-53. PubMed ID: 199352 [No Abstract] [Full Text] [Related]